| |
Arthritis News Archive18-Jun-2008
Bristol-Myers Squibb reports positive results from Phase II arthritis trial (Pharmaceutical Business Review)
Bristol-Myers Squibb has announced positive results from an exploratory Phase II study of 56 individuals that suggested that Orencia, a prescription drug for adults with moderate to severe rheumatoid arthritis, may delay the development of RA in people with undifferentiated inflammatory arthritis.
Heart Disease, Arthritis May Go Hand In Hand (KCTV 5 Kansas City)
Doctors treating people with rheumatoid arthritis need to be on the lookout for heart problems, a study says.
Conference on tackling arthritis to come to Keele (Sentinel)
A conference led by people taking part in long-term arthritis research projects in North Staffordshire will be staged in the autumn. Having a medical school on the doorstep and acclaimed rheumatology unit at the Haywood Hospital, Burslem, the ...
Researchers hail new arthritis drug (ABC via Yahoo!7 News)
A new drug which is described as a breakthrough in the treatment of rheumatoid arthritis is expected to be available in Australia within a couple of years.
Arthritis May Be Sign Of Heart Disease (Fox 12 Oregon)
The risk of heart problems in people with rheumatoid arthritis is about as high as for people with type 2 diabetes, according to a new study. Researchers from France found that 8.6 percent people with arthritis had a heart problem, about double the rate found in the general population.
New Treatment For Rheumatoid Arthritis Leaves 50 Percent Of Recent Onset Patients Symptom-free Within 36 Weeks (Science Daily)
At least 50 percent of recent onset rheumatoid arthritis patients achieve remission within 36 weeks when following a systematic approach of step-up DMARD treatment in combination with tight control, according to new results.
Risk Of Rheumatoid Arthritis And Juvenile Idiopathic Arthritis Increased By Early Life Infections (Medical News Today)
Infections during the first year of life are a marker of increased risk of developing specific types of arthritis later in life, according to new research from Sweden presented at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France.
Back to Alternative Treatments for Arthritis
Back to Arthritis News Archive
|
|
|